Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic.
Marcus CastilloBrianna ConteSam HinkesMegan MathewC J NaAinhoa NorindrDavid P SerotaDavid W ForrestAmar R DeshpandeTyler S BartholomewHansel E TookesPublished in: Harm reduction journal (2020)
TeleMOUD is feasible and successful in providing people who inject drugs with low barrier access to life-saving MOUD during the COVID-19 pandemic. This model also provided medical students with experience treating addiction during a time when they were restricted from most clinical activities.